Date Published: 8 October 2005

Researchers reveal structural basis for hereditary coproporphyria

Health News from the United States of America (USA)

Health News from the USA

A research team led by scientists at The University of Texas Medical School at Houston has determined the structure of an enzyme that when defective causes an inherited disease that afflicts sufferers with severe abdominal pain, psychiatric symptoms, skin fragility, and light sensitivity.

"Unless prompt and appropriate treatment is given, hereditary coproporphyria can very quickly turn into a life-threatening medical emergency,"
said C. S. Raman, Ph.D., assistant professor in the Department of Biochemistry and Molecular Biology and senior author of a paper out this week in the Proceedings of the National Academy of Sciences.


The CPO enzyme consists of two identical molecules.

Using x-ray crystallography, researchers have generated a three-dimensional image of the enzyme coproporphyrinogen oxidase (CPO) at the atomic level, (resolution of 1.58 angstroms). The enzyme participates in the sixth step of an eight-step pathway that generates heme ? an essential molecule that gives blood its distinctive red color and also helps hemoglobin in red blood cells transport oxygen to tissues.

The PNAS paper demonstrates for the first time the enzyme's atomic structure and how mutations in this enzyme specifically disrupt the heme pathway, causing hereditary coproporphyria. The authors review a series of CPO mutations and their effects on the structure and function of the enzyme.

"There will be no life without heme, so it is important to understand how this molecule is produced and utilized," Raman said. Hereditary coproporphyria is rare, affecting two in every million people, "but rare diseases give you major insights into extremely complex biological problems."

Porphyrias are disorders of enzymes in the heme synthesis pathway that reduce heme production and, more importantly, cause accumulation of porphyrins or their precursors, Raman explained. In the case of hereditary coproporphyria, inherited mutations in CPO result in accumulation of coproporphyrin in the liver, leading to disease. In July, British researchers connected the madness of King George III to one of the porphyrias.

"The atomic image of the enzyme teaches us the inner workings of this molecular machine. Particularly, it helps us understand how mutations cause the enzyme to fail, disrupt the heme biosynthesis pathway and culminate in coproporphyrin accumulation," Raman said.

Excess porphyrins are excreted in the feces and urine. As a result urine from patients suffering from coproporphyria turns red or purple when exposed to light.

The CPO structure is the third unique structure solved by Raman's research team, which focuses on heme and nitric oxide synthesis and signaling pathways.



Source: Texas University (USA) -

Also in the News:

How do carbapenemases destroy carbapenems ? - 9 Nov '12

How plasminogen is converted into an enzyme that removes disease-causing clots - 9 Mar '12

FDA approves two new pancreatic enzyme products, Ultresa and Viokace, to aid digestion - 1 Mar '12

Biocompatible artificial DNA linker - 1 Jul '11

Key step in the development of a norovirus treatment - 1 Feb '11

Recent research re. Chronic Granulomatous Disease - 30 Dec '10

Research could improve detection of liver damage - 17 Sep '10

Trial to test experimental drug for advanced pancreatic cancer - 2 Sep '10

Be a secret angel today: How many anonymous good turns can you do in just 24 hours ?

Although care has been taken when compiling this page, the information contained might not be completely up to date. Accuracy cannot be guaranteed. This material is copyright. See terms of use.

IvyRose Holistic 2003-2019.